In the ever-evolving stroke treatment market, groundbreaking advancements in drug formulations are transforming patient care. From minimizing internal bleeding to improving neuroplasticity, these innovations aim to improve outcomes for stroke patients worldwide. Two key players in this transformation are oral anticoagulants (NOACs) and tissue plasminogen activator (tPA) drugs, both of which have gained traction due [...]The post Stroke Treatment Market: Innovative Drugs and Therapies Driving Global Growth by 2034 appeared first on Transparency Market Research Blog.